SAMPLE ASAM EXPERTS Louis E. Baxter, Sr., MD, FASAM Dr. Baxter is the Immediate Past President of ASAM and Executive Medical Director of the Professional Assistance Program of New Jersey, Inc., located in Princeton, New Jersey and Medical Director, of the Division of Addiction Services for the New Jersey Department of Health and Senior Services. He is also an Instructor in Medicine at the Thomas Jefferson School of Medicine in Philadelphia, Pennsylvania. He maintains a private medical practice, Recovery Care Medical Associates. Dr. Baxter earned his MD in 1978 from Temple University School of Medicine and completed his internal medicine residency in 1981 at Cooper Hospital, University Medical Center in Camden, New Jersey. He specializes in addiction medicine and internal medicine. Lawrence S. Brown, Jr., MD, MPH, FASAM Dr. Brown is the Chief Executive Officer of START Treatment & Recovery Centers (formerly Addiction, Research and Treatment Corporation), located in Brooklyn, NY. His experience in nonprofit governance includes past service as president and board chair of the American Society of Addiction Medicine (ASAM); board chair of the U.S. Anti-Doping Agency; Board member of the College on Problems of Drug Dependence (CPDD); and Board member of the National Black Leadership Commission on AIDS. He has served as a member of the Drug Testing Advisory Board of the Substance Abuse and Mental Health Services Administration within the Department of Health and Human Services. He was recently appointed by the New York governor, and confirmed by the New York State Senate to serve as a member of both the state's Public Health and Health Planning Council and Behavioral Health Services Advisory Council. Other service on government committees includes the Food and Drug Administration, the National Institute on Drug Abuse and the National Institute of Allergy and Infectious Diseases. Outside of government, Dr. Brown serves as medical advisor to the National Football League. Dr. Brown received a combined MD/MPH degree from New York University School of Medicine and Columbia University School of Public Health. After completing an internal medicine residency at Harlem Hospital and a fellowship in neuroendocrinology at Columbia University College of Physicians and Surgeons, he subsequently received academic appointments as associate physician at 1
Rockefeller University Hospital and clinical associate professor of public health at Weill Cornell Medical College. Kelly Clark, MD, MBA, FASAM, DFAPA Dr. Clark is President-Elect of ASAM and current Chair of the Legislative Advocacy Committee. She is board certified in both addiction medicine and psychiatry, and has practiced extensively in private practice, emergency, acute, sub-acute, and chronic institutions; community, county, state, federal sites; and voluntary, involuntary and penal settings. She has worked or consulted in a variety of capacities including in expert review for utilization, disability, worker s compensation, and pharmacy benefit management organizations; for pharmaceutical companies; and as an independent psychiatric expert to the courts in Kentucky and Rhode Island. Having worked in opioid treatment programs utilizing methadone and buprenorphine, Dr. Clark has a deep appreciation for the role of multidisciplinary teams led by a physician. Her training as a psychiatrist led her to embrace a biopsychosocial approach to practicing medicine. Currently practicing addiction medicine in Appalachian Kentucky, Dr. Clark is the Chief Medical Officer of CleanSlate in Massachusetts, and a Medical Director at CVS Caremark where she addresses issues such as the overutilization of opioids and benzodiazepines. Having previously served as the Behavioral Health Medical Director for a non-profit health plan, CDPHP, her expertise in payment models, quality metrics, and payer and care delivery systems leads her to speak widely on issues of health care reform, parity, and medical-behavioral health integration. Dr. Clark earned an MBA from The Fuqua School of Business at Duke University, Durham, NC; her medical degree from University of Wisconsin, Madison, WI; and a bachelor degree in psychology from Coe College, Cedar Rapids, IA. She completed residency in psychiatry at the Medical College of Wisconsin. Dr. Clark served as faculty of the University of Massachusetts Medical School for eight years and trained students and resident physicians on the inpatient dual diagnosis unit as well as in outpatient, partial hospital, and consultative settings. A Fellow of the American Society of Addiction Medicine and a Distinguished Fellow of the American Psychiatric Association, Dr. Clark has served as a member of the Collaborative Care Research Network Steering Committee of the American Academy of Family Practice. She is currently a member of the Integrated Care Work Group of the American Psychiatric Association; the Substance Abuse and Mental Health Services Administration Expert Committee on Opioid Treatment Program Guidelines; the National Rx Drug Abuse Summit Advisory Board; and the faculty of the Virginia Tech Carilion School of Medicine. 2
Anthony H. Dekker, DO, FASAM Dr. Dekker is the director of the new division of Addiction Medicine at the Ft. Belvoir Community Hospital, which is one of the replacement hospitals for the Walter Reed Army Medical Center. He will be directing the team of clinical and research staff in the formation of a comprehensive evaluation and treatment program for substance abuse and dependence disorders in the military. After serving the Indian Health Service for over twelve years in Arizona he is honored to be a member of the Army Medical Team that will specialize in the care of Wounded Warriors. Previously he was the Acting Director of the Office of Health Programs at the Phoenix Area Office supervising 15 departments in Nevada, Utah and Arizona. He was also the Associate Director of the Phoenix Indian Medical Center. He completed his Osteopathic education at Michigan State University in 1978. He completed his internship and family medicine residency at the Chicago College of Osteopathic Medicine and an Adolescent and Young Adult Medicine fellowship at Rush-Presbyterian-St Luke s Medical Center in Chicago. As a Public Health Service Scholar he served Chicago s South Side for fourteen years. He was Professor and Chair of Family Medicine at the Kansas City University of Medicine and Biosciences and Clinical Associate Professor at the University of Kansas Medical Center and the University of Missouri-Kansas City (Children s Mercy Hospital) during his four years in Kansas City. Dr. Dekker is board certified in Family Practice and Osteopathic Manipulative Treatment, Adolescent and Young Adult Medicine, and Addiction Medicine. As a member of the healthcare team at the Fort Belvoir Community Hospital he is dedicated to the Mission of providing the highest quality care to active duty military and their dependents. His areas of expertise include addiction medicine, chronic pain syndromes, infomatics, high risk youth, domestic violence and behavioral health. Stuart Gitlow, MD, MPH, MBA, DFAPA Dr. Gitlow, current President of the ASAM Board of Directors, is the Executive Director of the Annenberg Physician Training Program in Addictive Disease, which he started in 2005 to ensure medical student access to training that stimulates them to develop and maintain interest in working with patients with addiction. He serves as Chair of the AMA s Council on Science and Public Health. Dr. Gitlow is the President of the American Society of Addiction Medicine, and serves as ASAM s delegate to the AMA. Board certified in general, addiction, and forensic psychiatry, Dr. Gitlow has an active addiction medicine practice. Graduate of MIT and Mount Sinai School of Medicine, Dr. Gitlow s 3
psychiatric and public health training took place in Pittsburgh, following which he went to Harvard for his forensic fellowship. Now dividing his time between his clinical practice in New England and his academic work in New York City, he is on faculty at both Dartmouth and Mount Sinai. Dr. Gitlow formerly produced both Health Channel and ABC programming at America Online. Yngvild Olsen, MD, MPH Dr. Yngvild Olsen graduated from Harvard Medical School in 1997, from the residency training program in internal medicine at Boston Medical Center in 2000, and from the Fellowship in General Internal Medicine at the Johns Hopkins School of Medicine in 2001. From July 2000 through June 2001, she served as Primary Care Chief Resident at Boston Medical Center. During her fellowship, she received a Masters in Public Health from the Johns Hopkins University Bloomberg School of Public Health. Dr. Olsen currently serves as Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services in Baltimore City. This is an outpatient substance use disorder treatment program that provides a broad range of services and includes a health home. She has previously served as the Vice President of Clinical Affairs for the Baltimore Substance Abuse Systems, where she played a central role in the expansion of buprenorphine treatment for opioid addiction in both the treatment and medical systems. She also has served as the Deputy Health Officer for the Harford County Health Department, where she oversaw local substance use treatment services, and as the Medical Director for the Johns Hopkins Hospital s outpatient substance use treatment services. Dr. Olsen has written and lectured extensively on opioid use disorder and its treatments. She has published in numerous journals, including the Journal of the American Medical Association, the New England Journal of Medicine, and the Journal of Addictive Diseases, on such topics as smoking in substance use treatment programs, the public health impact of buprenorphine treatment expansion, the stigma associated with medication-assisted treatment, and the dual challenges of pain treatment and addiction. As an addiction medicine specialist trained in internal medicine, she teaches appropriate opioid prescribing to primary care physicians and instructs on medical co-occurring conditions to psychiatrists and other behavioral health providers. She is the President of the Maryland Society of Addiction Medicine, an incoming member of the ASAM Board of Directors, the President of the Maryland Association for Treatment of Opioid Dependence, serves on the Maryland Overdose Prevention 4
Advisory Council, and is a member of the board of the Journey Home, Baltimore s effort to end homelessness. Mark Publicker, MD, FASAM Dr. Publicker is an addiction medicine specialist at the Mercy Hospital Recovery Center and Immediate Past President of the Northern New England Society of Addiction Medicine (Maine, New Hampshire and Vermont). He is a Fellow of the American Society of Addiction Medicine and is a Diplomate of the American Board of Addiction Medicine. He is an Associate Professor of Clinical Medicine at the University of New England College of Osteopathic Medicine, the University of Vermont College of Medicine and Tufts University School of Medicine. He was a co-principle investigator in the Clinical Trial Network study on the treatment of opioid-addicted youth. (2008). In April, 2007, he was invited to China as a visiting professor to teach addiction medicine at the Peking University Institute of Mental Health and at the Yunnan Addiction Institute in Kunming and returned to Beijing in March, 2008 and in April, 2010 he returned to teach at Ningbo University School of Medicine and at Anding Hospital in Beijing. In June and November 2008, he traveled to Turkey to help establish a residential treatment program for inhalant-addicted street children in Anatolia. In 2009, he was named Caregiver of the Year by the Maine Hospital Association. 5